Know Cancer

or
forgot password
  • cancer clinical trials in moline, IL

  • Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Breast Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Stoffel, Thomas J MD (UIA Investigator)

    Trial Locations
    Stoffel, Thomas J MD (UIA Investigator)
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Leukemia
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Stoffel, Thomas J MD (UIA Investigator)

    Trial Locations
    Stoffel, Thomas J MD (UIA Investigator)
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Sharis, Christine M MD (UIA Investigator)

    Trial Locations
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Trinity Medical Center

    Trial Locations
    Trinity Medical Center
    Garneau, Stewart C MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Porubcin, Michael MD (UIA Investigator)

    Trial Locations
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Garneau, Stewart C MD (UIA Investigator)

    Trial Locations
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Garneau, Stewart C MD (UIA Investigator)

    Trial Locations
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Trinity Medical Center

    Trial Locations
    Trinity Medical Center
    Garneau, Stewart C MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Garneau, Stewart C MD (UIA Investigator)

    Trial Locations
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Liver Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Trinity Medical Center

    Trial Locations
    Trinity Medical Center
    Stoffel, Thomas J MD (UIA Investigator)
    Garneau, Stewart C MD (UIA Investigator)
    Sharis, Christine M MD (UIA Investigator)
    Porubcin, Michael MD (UIA Investigator)
    Spector, David MD (UIA Investigator)
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Carcinoma of Unknown Primary
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Lung Cancer
    Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Breast Cancer, Hot Flashes, Menopausal Symptoms, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Melanoma (Skin)
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Study of Tissue and Blood Samples From Patients With High-Grade Glioma
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Brain and Central Nervous System Tumors
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
    Moline, Illinois 61265
    Lung Cancer